Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

OPGN

OpGen (OPGN)

OpGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OPGN
DateTimeSourceHeadlineSymbolCompany
12/18/20187:30AMGlobeNewswire Inc.OpGen Completes CDC Contract to Develop Clinical Support Mobile-Based Tools for Antimicrobial Stewardship and Infection Contr...NASDAQ:OPGNOpGen Inc
12/04/20187:30AMGlobeNewswire Inc.OpGen Receives Regulatory Approval to Market Pathogen Identification Products in ColombiaNASDAQ:OPGNOpGen Inc
11/21/20184:48PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
11/21/20184:43PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
11/14/20182:16PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
11/14/20182:13PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
11/14/20182:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPGNOpGen Inc
11/13/20184:02PMGlobeNewswire Inc.OpGen Reports third quarter 2018 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
11/06/20187:30AMGlobeNewswire Inc.OpGen Completes Specimen Accrual and Testing in Acuitas® Clinical Verification StudyNASDAQ:OPGNOpGen Inc
11/05/20185:23PMGlobeNewswire Inc.OpGen Announces Date of Third Quarter 2018 Financial Results Conference CallNASDAQ:OPGNOpGen Inc
10/31/20187:30AMGlobeNewswire Inc.OpGen Collaborates With QIAGEN to Advance Rapid Diagnostics for Antimicrobial Resistant BacteriaNASDAQ:OPGNOpGen Inc
10/18/20182:37PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
10/18/20182:36PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
10/18/20181:56PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
10/18/20181:56PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
10/18/20188:14AMGlobeNewswire Inc.OpGen Announces Pricing of Public Offering of Common StockNASDAQ:OPGNOpGen Inc
10/18/20186:08AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
10/17/20184:18PMGlobeNewswire Inc.OpGen Announces Proposed Public Offering of Common StockNASDAQ:OPGNOpGen Inc
10/16/20185:07PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
10/16/20185:06PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
10/16/20185:00PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
10/15/20185:35PMGlobeNewswire Inc.OpGen Provides Business and Preliminary Financial UpdateNASDAQ:OPGNOpGen Inc
09/26/20185:30PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
09/26/20185:29PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OPGNOpGen Inc
09/25/201811:22AMGlobeNewswire Inc.OpGen to Present at Two Upcoming Investment Conferences in OctoberNASDAQ:OPGNOpGen Inc
09/25/20186:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
09/24/20185:25PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
09/24/20189:26AMGlobeNewswire Inc.OpGen Partnering with New York State Department of Health and Merck’s ILÚM Health Solutions to Detect Antimicrobial-Resist...NASDAQ:OPGNOpGen Inc
08/29/201811:40AMGlobeNewswire Inc.OpGen to Present at the 20th Annual Rodman & Renshaw Global Investment ConferenceNASDAQ:OPGNOpGen Inc
08/09/20184:09PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OPGNOpGen Inc
 Showing the most relevant articles for your search:NASDAQ:OPGN